Plus   Neg

Stock Alert: Baidu Drops 6%

Shares of Chinese search engine Baidu, Inc. (BIDU) are down more than 6% Friday morning on the news of its streaming platform iQIYI is being probed by SEC on alleged fraud.

Thursday the company reported second-quarter results with earnings on an adjusted basis of $2.08 per ADS, that beat the average estimate of analysts polled by Thomson Reuters at $1.38.

Revenues for the quarter decreased 1% year-over-year to $3.69 billion.

For the third quarter, Baidu expects revenues to be between $3.7 billion and $4.1 billion. The consensus estimate is at $3.97 billion.

BIDU is currently trading at $116.73. It has traded in the range of $82- $147.38 in the last one year.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration (FDA) has gone ahead with the approval of antiviral drug remdesivir as first treatment for COVID-19, notwithstanding last week's findings by the World Health Organization (WHO) that the drug is not effective for COVID-19 treatment. Thursday, Gilead Sciences announced that the FDA approved remdesivir, sold under the brand name Veklury. Integrated payments firm American Express Co. (AXP) reported Friday that net income for the third quarter declined to $1.1 billion or $1.30 per share from $1.8 billion or $2.08 per share in the prior-year quarter. Consolidated total revenues, net of interest expense, also decreased 20 percent to $8.8... The Federal Trade Commission or FTC has launched a new fraud reporting platform, using which, consumers can easily report fraud and all other consumer issues directly to the regulator. In a statement, the FTC said its new website, ReportFraud.ftc.gov, will provide a streamlined and user-friendly way to submit reports about scams, frauds, and bad business practices.
Follow RTT